AR and type 2 diabetes mellitus: used testosterone to stimulate cardiomyocytes in vitro and determined that testosterone accelerated glucose consumption by activating AMPK and AR signaling pathways, suggesting that the response to testosterone deficiency might be a key factor promoting CAD occurrence in men with T2DM (32).